InvestorsHub Logo

Lemoncat

09/13/22 10:12 PM

#393171 RE: Blue Fin #393166

I can't help but notice Amgen never went from $4.60 to $0.03 and never had <10 employees.

It's almost like Amgen was a legitimate pharma company that built value over time with consistent results and a steady mission.

Ours looks a lot more like this one in terms of chart and mission:

https://www.bing.com/search?q=NNVC&qs=n&form=QBRE&sp=-1&pq=nnvc&sc=10-4&sk=&cvid=35BD2CFF72D444BFB94D3E28AC512B34&ghsh=0&ghacc=0&ghpl=

You know...constantly changing direction while losing 99% of shareholder value while the CEO gets bankrolled.